SLC5A2 and acute kidney injury: To investigate the effects of different SGLT2 inhibitors on AKI risk, a recent experiment compared the effects of empagliflozin and canagliflozin in a rat model of AKI using SCr and blood urea nitrogen (BUN) as indicators of AKI [90].